Tevfik DEMİR
(Dokuz Eylül Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, İzmir, Türkiye)
Barış AKINCI
(Dokuz Eylül Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, İzmir, Türkiye)
Sena YEŞİL
(Dokuz Eylül Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, İzmir, Türkiye)
Yıl: 2007Cilt: 21Sayı: 1ISSN: 1300-6622 / 2602-3148Sayfa Aralığı: 63 - 70Türkçe

193 3
Diyabetik ayak ülserlerinin tanı ve tedavisi
Diyabetik ayak ülserleri diyabetin sık görülen ve ciddi bir kronik komplikasyonudur. Diyabetik ayak ülserleri diyabetik hastalarda önemli bir morbidite ve mortalite nedenidir. Diyabetik ayak ülserlerinin izlem ve tedavisi periferik arter hastalığı, nöropati, travma ve enfeksiyon gibi ilişkili nedenler doğrultusunda bireyselleştirilmelidir. Cerrahi ve cerrahi dışı temel yara bakımı prensipleri bu yaraların etkin bir şekilde iyileşmesinde vazgeçilmez bir unsurdur. Ayak ülseri oluşumunun önlenmesi de tedavisi kadar önemlidir ve diyabetin bu ciddi komplikasyonuna karşı en ekonomik yaklaşımıdır. Bu yazıda diyabetik ayak ülserleri nedenleri ve patofizyolojisi birlikte incelenmiş, klinik değerlendirme ve tedavi seçenekleri gözden geçirilmiştir.
Fen > Tıp > Cerrahi
DergiDiğerErişime Açık
  • 1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al. The global burden of diabetic foot disease. Lancet 2005; 366:1719-1724. 2. Jeffcoate WJ, Harding KG: Diabetic foot ulcers. Lancet 2003; 361:1545-1551. 3. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22:157-162. 4. Calhoun JH, Cantrell J, Cobos J, et al. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle 1988; 9:101-106. 5. Armstrong DG, Liswood PJ, Todd WF. 1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J Am Podiatr Med Assoc 1995; 85:533-537. 6. Edmonds ME. Progress in care of the diabetic foot. Lancet 1999; 354:270-272. 7. Bus SA, Yang QX, Wang JH, et al. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care 2002; 25:1444-1450. 8. Aye M, Masson EA. Dermatological care of the diabetic foot. Am J Clin Dermatol 2002; 3:463-474. 9. Katoulis EC, Boulton AJ, Raptis SA. The role of diabetic neuropathy and high plantar pressures in the pathogenesis of foot ulceration. Horm Metab Res 1996; 28:159-164. 10. Murray HJ, Young MJ, Hollis S, et al. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996; 13:979-982. 11. Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care 2004; 27:942-946. 12. Connor H, Mahdi OZ. Repetitive ulceration in neuropathic patients. Diabetes Metab Res Rev 2004; 20:23-28. 13. Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification
  • systems. Diabetes Care 2001; 24:84-88. 14. Treece KA, Macfarlane RM, Pound N, et al. Validation of a system of foot ulcer classification in diabetes mellitus. Diabet Med 2004; 21:987-991. 15. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20:90-95. 16. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885-910. 17. Dyet JF, Nicholson AA, Ettles DF. Vascular imaging and intervention in peripheral arteries in the diabetic patient. Diabetes Metab Res Rev 2000; 16: 16-22. 18. Lepantalo M, Biancari F, Tukiainen E. Never amputate without consultation of a vascular surgeon. Diabetes Metab Res Rev 2000; 16: 27-32. 19. Bailey CM, Saha S, Magee TR, et al. A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2003; 25:131-134. 20. Andros G. Diagnostic and therapeutic arterial interventions in the ulcerated diabetic foot. Diabetes Metab Res Rev 2004; 20: 29-33. 21. Adam DJ, Raptis S, Fitridge RA. Trends in the presentation and surgical management of the acute diabetic foot. Eur J Vasc Endovasc Surg 2006; 31:151-156. 22. Caruana MF, Bradbury AW, Adam DJ. The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. Eur J Vasc Endovasc Surg 2005; 29:443-451. 23. Faries PL, Teodorescu VJ, Morrissey NJ, et al. The role of surgical revascularization in the management of diabetic foot wounds. Am J Surg 2004; 187:34S-37S. 24. Lipsky BA, Berendt AR, Embil J, et al. Diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2004; 20: 56-64. 25. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg 2006; 117:212-238. 26. Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. Jama 1995; 273:721- 723. 27. Cavanagh PR, Lipsky BA, Bradbury AW, et al. Treatment for diabetic foot ulcers. Lancet 2005; 366:1725-1735. 28. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am 2002; 40:1171-1192. 29. Becker W. Imaging osteomyelitis and the diabetic foot. Q J Nucl Med 1999; 43:9-20. 30. Lipsky BA. A Current Approach to Diabetic Foot Infections. Curr Infect Dis Rep 1999; 1:253-260. 31. Lipsky BA, Pecoraro RE, Wheat LJ The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am 1990; 4:409-432. 32. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997; 25:1318-1326. 33. Cunha BA. Antibiotic selection for diabetic foot infections: a review. J Foot Ankle Surg 2000; 39:253-257. 34. Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol 1999; 26:267-276. 35. Kaye ET. Topical antibacterial agents: role in prophylaxis and treatment of bacterial infections. Curr Clin Top Infect Dis 2000; 20:43-62. 36. Rayman G, Rayman A, Baker NR, et al. Sustained silverreleasing dressing in the treatment of diabetic foot ulcers. Br J Nurs 2005; 14:109-114. 37. Karr JC. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate. J Am Podiatr Med Assoc 2002; 92:314; author reply 314-315. 38. Steed DL. Foundations of good ulcer care. Am J Surg 1998; 176:20-25. 39. Bates MC, Aburahma AF. An update on endovascular therapy of the lower extremities. J Endovasc Ther 2004; 11:107-127. 40. Armstrong DG, Nguyen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001; 24:1019-1022. 41. Armstrong DG, Lavery LA, Wu S, et al. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005; 28:551-554. 42. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. Bmj 2003; 326: 584-588. 43. Hobbs SD, Bradbury AW. Smoking cessation strategies
  • in patients with peripheral arterial disease: an evidencebased approach. Eur J Vasc Endovasc Surg 2003; 26:341-347. 44. Hobbs SD, Wilmink AB, Adam DJ, et al. Assessment of smoking status in patients with peripheral arterial disease. J Vasc Surg 2005; 41:451-456. 45. Hobbs SD, Jones A, Wilmink AB, et al. Near patient cholesterol testing in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2003; 26:267-271. 46. Prisant LM. Clinical trials and lipid guidelines for type II diabetes. J Clin Pharmacol 2004; 44:423-430. 47. Hirsh J, Bhatt DL. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med 2004; 164:2106-2110. 48. Whaley-Connell A, Sowers JR. Hypertension management in type 2 diabetes mellitus: recommendations of the Joint National Committee VII. Endocrinol Metab Clin North Am 2005; 34:63-75. 49. Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev 2004; 20:78-89. 50. Crane M, Werber B. Critical pathway approach to diabetic pedal infections in a multidisciplinary setting. J Foot Ankle Surg 1999; 38:30-33; discussion 82-33. 51. Dargis V, Pantelejeva O, Jonushaite A, et al. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999; 22:1428-1431. 52. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22:382-387. 53. Wieman TJ, Mercke YK, Cerrito PB, et al. Resection of the metatarsal head for diabetic foot ulcers. Am J Surg 1998; 176:436-441. 54. Mantey I, Foster AV, Spencer S, et al. Why do foot ulcers recur in diabetic patients? Diabet Med 1999; 16:245-249. 55. Chantelau E, Kushner T, Spraul M. How effective is cushioned therapeutic footwear in protecting diabetic feet? A clinical study. Diabet Med 1990; 7:355-359. 56. Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev 2005:CD001488. 57. Griffiths GD, Wieman TJ. Meticulous attention to foot care improves the prognosis in diabetic ulceration of the foot. Surg Gynecol Obstet 1992; 174:49-51. 58. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995; 18:1376-1378. 59. Busch K, Chantelau E. Effectiveness of a new brand of stock 'diabetic' shoes to protect against diabetic foot ulcer relapse. A prospective cohort study. Diabet Med 2003; 20:665-669. 60. Demir T, Yesil S, Akinci B, et al. Predictors Of Major Amputatıons In Dıabetıc Foot Ulcers: Evaluatıon Of Episodes In 232 Patıents From Western Turkey. In ENDO 2006. Boston, USA, 2006.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.